Stay updated with breaking news from 03475v10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
AngioDynamics (NASDAQ:ANGO – Get Rating) had its price target lowered by equities researchers at Raymond James from $22.00 to $14.00 in a research report issued to clients and investors on Monday, Benzinga reports. The brokerage currently has a “strong-buy” rating on the medical instruments supplier’s stock. Raymond James’ price objective would indicate a potential upside […]
AngioDynamics (NASDAQ:ANGO – Get Rating) updated its FY 2023 earnings guidance on Friday. The company provided EPS guidance of -$0.06–$0.01 for the period, compared to the consensus EPS estimate of -$0.01. The company issued revenue guidance of $338.00 million-$342.00 million, compared to the consensus revenue estimate of $342.47 million. Analyst Upgrades and Downgrades A number […]
AngioDynamics (NASDAQ:ANGO – Get Rating) posted its quarterly earnings results on Thursday. The medical instruments supplier reported ($0.03) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.01) by ($0.02), Briefing.com reports. AngioDynamics had a negative net margin of 9.98% and a negative return on equity of 0.14%. The business had revenue of […]
AngioDynamics (NASDAQ:ANGO – Get Rating) posted its quarterly earnings results on Thursday. The medical instruments supplier reported ($0.03) earnings per share for the quarter, missing the consensus estimate of ($0.01) by ($0.02), Briefing.com reports. The business had revenue of $80.70 million during the quarter, compared to analysts’ expectations of $83.20 million. AngioDynamics had a negative […]
AngioDynamics (NASDAQ:ANGO – Get Rating) issued an update on its FY 2023 earnings guidance on Friday morning. The company provided earnings per share (EPS) guidance of -$0.06–$0.01 for the period, compared to the consensus estimate of -$0.01. The company issued revenue guidance of $338.00 million-$342.00 million, compared to the consensus revenue estimate of $342.47 million. […]